# FDA EIR - Rentschler Biopharma SE - February 15, 2022

Source: https://www.globalkeysolutions.net/records/eir/rentschler-biopharma-se/d3900ca0-3215-45e5-b136-19fb4ba548b9

> FDA EIR for Rentschler Biopharma SE on February 15, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Rentschler Biopharma SE
- Inspection Date: 2022-02-15
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2022-02-15](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/dd46571c-c83f-449f-a4c7-b1b10e214eae)
- [483 - 2023-03-07](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-se/a356438e-6da6-487c-a025-d6d0b1b6c608)

## Related Officers

- [ Investigator, Consumer Safety Officer](https://www.globalkeysolutions.net/people/thuy-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
- [Ralph M. Bernstein](https://www.globalkeysolutions.net/people/ralph-m-bernstein/72173dfb-24ae-42a1-af9e-1dc7da02ed87)
- [Quality System Specialist](https://www.globalkeysolutions.net/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)
- [Bo Chi](https://www.globalkeysolutions.net/people/bo-chi/9c83477d-58c1-4183-832e-ce8cbd25a521)
- [Senior Regulatory Specialist](https://www.globalkeysolutions.net/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)

Company: https://www.globalkeysolutions.net/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c